{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T09:35:18Z","timestamp":1793957718904,"version":"4.8.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T00:00:00Z","timestamp":1648857600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T00:00:00Z","timestamp":1648857600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Anti-M\u00fcllerian hormone (AMH) is used as a biomarker to estimate ovarian reserve. The relationship between AMH and early miscarriage of in vitro fertilization (IVF) is still inconclusive. This study aimed to explore whether serum AMH levels are associated with early miscarriage rates after\u00a0in vitro fertilization\/intracytoplasmic sperm injection (IVF\/ICSI) with fresh embryo transfer (ET).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This retrospective cohort study included 2246 patients undergoing their first oocyte retrievals for IVF\/ICSI with fresh embryos transferred to Tianjin Central Hospital of Gynecology Obstetrics between May 2018 and March 2020. The serum AMH levels of the patients were measured within 12\u00a0months before the IVF\/ICSI cycles. All women were divided into a low-AMH group, medium-AMH group and high-AMH group. Binary logistic regression was applied to confirm whether the serum AMH level was associated with the risk of early miscarriage independent of potential confounders, such as age, body mass index (BMI), duration of infertility, main diagnosis, history of internal medicine diseases, number of oocytes retrieved and high-quality embryo rate.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The early miscarriage rate was significantly lower in the medium-AMH group than in either the low-AMH or high-AMH group among young (&lt;\u200935\u00a0years) women (<jats:italic>P<\/jats:italic>\u2009=\u20090.015). In women above 35\u00a0years of age, the early miscarriage rates in the three AMH groups were not significantly different. Young women with high serum AMH levels had a significantly higher risk of early miscarriage regardless of age or other potential confounders (adjusted odds ratio (OR) 2.382, 95% confidence interval (CI) 1.246 to 4.553, <jats:italic>P<\/jats:italic>\u2009=\u20090.009). The results remained similar after restricting the analysis to women without polycystic ovary syndrome (PCOS).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>With a high AMH level, young women had a higher risk of early miscarriage than women with a medium AMH level in their first IVF\/ICSI treatment. In young women, serum AMH levels were independently associated with the risk of early miscarriage after IVF-ET treatment. Serum AMH levels might be a valuable marker to estimate the risk of early miscarriage. It is worth noting to the clinical value of AMH.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12884-022-04591-5","type":"journal-article","created":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T11:03:24Z","timestamp":1648897404000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Serum anti-M\u00fcllerian hormone levels are associated with early miscarriage in the IVF\/ICSI fresh cycle"],"prefix":"10.1186","volume":"22","author":[{"given":"Xin","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunshan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aijun","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruqiang","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiabei","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haining","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,2]]},"reference":[{"key":"4591_CR1","unstructured":"Chandra A, Copen CE, Stephen EH. Infertility and Impaired Fecundity in the United States, 1982\u20132010: Data From the National Survey of Family Growth. US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics; 2013."},{"key":"4591_CR2","doi-asserted-by":"publisher","first-page":"l869","DOI":"10.1136\/bmj.l869","volume":"364","author":"MC Magnus","year":"2019","unstructured":"Magnus MC, Wilcox AJ, Morken NH, Weinberg CR, Haberg SE. Role of maternal age and pregnancy history in risk of miscarriage: prospective register based study. BMJ. 2019;364:l869.","journal-title":"BMJ"},{"key":"4591_CR3","doi-asserted-by":"crossref","unstructured":"Lancet T. Miscarriage: worldwide reform of care is needed. Lancet. 2021;397(10285):1597.","DOI":"10.1016\/S0140-6736(21)00954-5"},{"issue":"1\u20132","key":"4591_CR4","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S0303-7207(98)00171-3","volume":"145","author":"E Velde","year":"1998","unstructured":"Velde E, Scheffer GJ, Dorland M, Broekmans FJ, Fauser B. Developmental and endocrine aspects of normal ovarian aging. Mol Cell Endocrinol. 1998;145(1\u20132):67\u201373.","journal-title":"Mol Cell Endocrinol"},{"issue":"6","key":"4591_CR5","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1093\/humrep\/17.6.1519","volume":"17","author":"T El-Toukhy","year":"2002","unstructured":"El-Toukhy T, Khalaf Y, Hart R, Taylor A, Braude P. Young age does not protect against the adverse effects of reduced ovarian reserve--an eight year study. Hum Reprod. 2002;17(6):1519\u201324.","journal-title":"Hum Reprod"},{"issue":"9","key":"4591_CR6","first-page":"1084","volume":"66","author":"Z Jamil","year":"2016","unstructured":"Jamil Z, Perveen K, Malik R, Avesi L. Serum anti-mullerian hormone: Correlation with the ovarian follicular dynamics in healthy mice. J Pak Med Assoc. 2016;66(9):1084\u20138.","journal-title":"J Pak Med Assoc"},{"issue":"1","key":"4591_CR7","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.fertnstert.2006.06.019","volume":"87","author":"JM Smeenk","year":"2007","unstructured":"Smeenk JM, Sweep FC, Zielhuis GA, Kremer JA, Thomas CM, Braat DD. Antimullerian hormone predicts ovarian responsiveness, but not embryo quality or pregnancy, after in vitro fertilization or intracyoplasmic sperm injection. Fertil Steril. 2007;87(1):223\u20136.","journal-title":"Fertil Steril"},{"key":"4591_CR8","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/del421","volume-title":"Anti-Mullerian hormone measurement on any day of the menstrual cycle strongly predicts ovarian response in assisted reproductive technology","author":"AL Marca","year":"2007","unstructured":"Marca AL, Giulini S, Tirelli A, Bertucci E, Marsella T, Xella S, et al. Anti-Mullerian hormone measurement on any day of the menstrual cycle strongly predicts ovarian response in assisted reproductive technology. 2007."},{"issue":"1","key":"4591_CR9","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/j.1479-828X.2005.00332.x","volume":"45","author":"KP Tremellen","year":"2005","unstructured":"Tremellen KP, Kolo M, Gilmore A, Lekamge DN. Anti-mullerian hormone as a marker of ovarian reserve. Aust N Z J Obstet Gynaecol. 2005;45(1):20\u20134.","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"2","key":"4591_CR10","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1097\/GRF.0000000000000436","volume":"62","author":"E Granger","year":"2019","unstructured":"Granger E, Tal R. Anti-M\u00fcllerian Hormone and Its Predictive Utility in Assisted Reproductive Technologies Outcomes. Clin Obstet Gynecol. 2019;62(2):238\u201356.","journal-title":"Clin Obstet Gynecol"},{"issue":"1","key":"4591_CR11","first-page":"24","volume":"10","author":"M Goswami","year":"2017","unstructured":"Goswami M, Nikolaou D. Is AMH Level, Independent of Age, a Predictor of Live Birth in IVF? J Hum Reprod Sci. 2017;10(1):24\u201330.","journal-title":"J Hum Reprod Sci"},{"issue":"3","key":"4591_CR12","doi-asserted-by":"publisher","first-page":"223.e1","DOI":"10.1016\/j.ajog.2011.04.035","volume":"205","author":"AS Blazar","year":"2011","unstructured":"Blazar AS, Lambert-Messerlian G, Hackett R, Krotz S, Carson SA, Robins JC, et al. Use of in-cycle antim\u00fcllerian hormone levels to predict cycle outcome. Am J Obstet Gynecol. 2011;205(3):223.e1-e5.","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"4591_CR13","first-page":"1755","volume":"8","author":"L Yao","year":"2015","unstructured":"Yao L, Wei Z, Hong L, Lin W. The role of serum AMH and FF AMH in predicting pregnancy outcome in the fresh cycle of IVF\/ICSI: a meta-analysis. Int J Clin Exp Med. 2015;8(2):1755\u201367.","journal-title":"Int J Clin Exp Med"},{"issue":"7","key":"4591_CR14","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s10815-012-9754-6","volume":"29","author":"S Sahmay","year":"2012","unstructured":"Sahmay S, Demirayak G, Guralp O, Ocal P, Senturk LM, Oral E, et al. Serum anti-mullerian hormone, follicle stimulating hormone and antral follicle count measurement cannot predict pregnancy rates in IVF\/ICSI cycles. J Assist Reprod Genet. 2012;29(7):589\u201395.","journal-title":"J Assist Reprod Genet"},{"issue":"4","key":"4591_CR15","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/35066065","volume":"2","author":"T Hassold","year":"2001","unstructured":"Hassold T, Hunt P. To err (meiotically) is human: the genesis of human aneuploidy. Nat Rev Genet. 2001;2(4):280\u201391.","journal-title":"Nat Rev Genet"},{"issue":"1","key":"4591_CR16","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/S1472-6483(10)62055-X","volume":"6","author":"A Kuliev","year":"2003","unstructured":"Kuliev A, Cieslak J, Ilkevitch Y, Verlinsky Y. Chromosomal abnormalities in a series of 6733 human oocytes in preimplantation diagnosis for age-related aneuploidies. Reprod Biomed Online. 2003;6(1):54\u20139.","journal-title":"Reprod Biomed Online"},{"issue":"3","key":"4591_CR17","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.fertnstert.2017.07.001","volume":"108","author":"B Tarasconi","year":"2017","unstructured":"Tarasconi B, Tadros T, Ayoubi JM, Belloc S, de Ziegler D, Fanchin R. Serum antimullerian hormone levels are independently related to miscarriage rates after in vitro fertilization-embryo transfer. Fertil Steril. 2017;108(3):518\u201324.","journal-title":"Fertil Steril"},{"issue":"5","key":"4591_CR18","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/S1472-6483(10)61053-X","volume":"14","author":"DN Lekamge","year":"2007","unstructured":"Lekamge DN, Barry M, Kolo M, Lane M, Gilchrist R, Tremellen K. Anti-Mullerian Hormone as a predictor of IVF outcome. Reprod Biomed Online. 2007;14(5):602\u201310.","journal-title":"Reprod Biomed Online"},{"issue":"6","key":"4591_CR19","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1080\/19396368.2020.1806944","volume":"66","author":"S Hong","year":"2020","unstructured":"Hong S, Chang E, Han EJ, Min SG, Kim S, Kang MK, et al. The anti-Mullerian hormone as a predictor of early pregnancy loss in subfertile women. Syst Biol Reprod Med. 2020;66(6):370\u20137.","journal-title":"Syst Biol Reprod Med"},{"key":"4591_CR20","volume-title":"Evaluation of the Anti-M\u00fcllerian Hormone and its Association with Embryo Quality in Advanced Reproductive Treatments in a Latin American Population","author":"HSG Morales","year":"2021","unstructured":"Morales HSG, L\u00f3pez GGP, Cort\u00e9s DV, Torres GCR, Hern\u00e1ndez HS, Guiot ML, et al. Evaluation of the Anti-M\u00fcllerian Hormone and its Association with Embryo Quality in Advanced Reproductive Treatments in a Latin American Population. 2021."},{"issue":"8","key":"4591_CR21","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1093\/humrep\/del171","volume":"21","author":"F Zegers-Hochschild","year":"2006","unstructured":"Zegers-Hochschild F, Nygren K-G, Adamson GD, de Mouzon J, Lancaster P, Mansour R, et al. The ICMART glossary on ART terminology*. Hum Reprod. 2006;21(8):1968\u201370.","journal-title":"Hum Reprod"},{"issue":"6","key":"4591_CR22","first-page":"347","volume":"79","author":"S Preutthipan","year":"1996","unstructured":"Preutthipan S, Amso N, Curtis P, Shaw RW. Effect of maternal age on clinical outcome in women undergoing in vitro fertilization and embryo transfer (IVF-ET). J Med Assoc Thai. 1996;79(6):347\u201352.","journal-title":"J Med Assoc Thai"},{"issue":"10","key":"4591_CR23","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1007\/s10815-015-0570-7","volume":"32","author":"KC Humm","year":"2015","unstructured":"Humm KC, Dodge LE, et al. In vitro fertilization in women under 35: counseling should differ by age. J Assist Reprod Genet. 2015;32(10):1449\u201357.","journal-title":"J Assist Reprod Genet"},{"issue":"5","key":"4591_CR24","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10815-016-0675-7","volume":"33","author":"A Revelli","year":"2016","unstructured":"Revelli A, Biasoni V, Gennarelli G, Canosa S, Dalmasso P, Benedetto C, et al. IVF results in patients with very low serum AMH are significantly affected by chronological age. J Assist Reprod Genet. 2016;33(5):603\u20139.","journal-title":"J Assist Reprod Genet"},{"key":"4591_CR25","doi-asserted-by":"publisher","first-page":"327","DOI":"10.3389\/fendo.2018.00327","volume":"9","author":"D Cimadomo","year":"2018","unstructured":"Cimadomo D, Fabozzi G, Vaiarelli A, Ubaldi N, Ubaldi FM, Rienzi L. Impact of Maternal Age on Oocyte and Embryo Competence. Front Endocrinol (Lausanne). 2018;9:327.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"4591_CR26","doi-asserted-by":"crossref","unstructured":"Morin SJ, Patounakis G, Juneau CR, Neal SA, Scott RT, Seli EJHR. Diminished ovarian reserve and poor response to stimulation in patients <38 years old: a quantitative but not qualitative reduction in performance. Hum Reprod. 2018;33(8):1489-98.","DOI":"10.1093\/humrep\/dey238"},{"issue":"1","key":"4591_CR27","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/ijgo.13104","volume":"149","author":"M Kostrzewa","year":"2020","unstructured":"Kostrzewa M, \u017by\u0142a M, Garnysz K, Kaczmarek B, Szy\u0142\u0142o K, Grzesiak M. Anti-M\u00fcllerian hormone as a marker of abortion in the first trimester of spontaneous pregnancy. Int J Gynaecol Obstet. 2020;149(1):66\u201370.","journal-title":"Int J Gynaecol Obstet"},{"issue":"1","key":"4591_CR28","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s12967-016-0924-7","volume":"14","author":"N Gleicher","year":"2016","unstructured":"Gleicher N, Kushnir VA, Sen A, Darmon SK, Weghofer A, Wu Y-G, et al. Definition by FSH, AMH and embryo numbers of good-, intermediate- and poor-prognosis patients suggests previously unknown IVF outcome-determining factor associated with AMH. J Transl Med. 2016;14(1):172.","journal-title":"J Transl Med"},{"key":"4591_CR29","unstructured":"Szafarowska M, Molinska-Glura M, Jerzak MMJNEL. Anti-M\u00fcllerian hormone concentration as a biomarker of pregnancy success or failure. Neuro Endocrinol Lett. 2014;35(4):322-6."},{"issue":"3","key":"4591_CR30","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s00404-015-3901-0","volume":"293","author":"R Gomez","year":"2016","unstructured":"Gomez R, Schorsch M, Hahn T, Henke A, Hoffmann I, Seufert R, Skala C. The influence of AMH on IVF success. J Arch Gynecol Obstet. 2016;293(3):667\u201373.","journal-title":"J Arch Gynecol Obstet"},{"issue":"11","key":"4591_CR31","doi-asserted-by":"publisher","first-page":"4891","DOI":"10.1210\/endo.142.11.8486","volume":"142","author":"ALL Durlinger","year":"2001","unstructured":"Durlinger ALL, Gruijters MJG, Kramer P, Karels B, Kumar TR, Matzuk MM, et al. Anti-Mu\u0308llerian Hormone Attenuates the Effects of FSH on Follicle Development in the Mouse Ovary. Endocrinology. 2001;142(11):4891\u20139.","journal-title":"Endocrinology"},{"issue":"9","key":"4591_CR32","doi-asserted-by":"publisher","first-page":"4399","DOI":"10.1210\/jc.2010-0334","volume":"95","author":"D Dewailly","year":"2010","unstructured":"Dewailly D, Pigny P, Soudan BT, Catteau-Jonard S, Decanter C, Poncelet E, et al. Reconciling the Definitions of Polycystic Ovary Syndrome: The Ovarian Follicle Number and Serum Anti-Mu\u0308llerian Hormone Concentrations Aggregate with the Markers of Hyperandrogenism. J Clin Endocrinol Metab. 2010;95(9):4399\u2013405.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"4591_CR33","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1210\/jcem.87.2.8207","volume":"87","author":"DJ Jakubowicz","year":"2002","unstructured":"Jakubowicz DJ, Iuorno MJ, Jakubowicz S, Roberts KA, Nestler JE. Effects of Metformin on Early Pregnancy Loss in the Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 2002;87(2):524\u20139.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"4591_CR34","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1530\/REP-07-0119","volume":"134","author":"E Nilsson","year":"2007","unstructured":"Nilsson E, Rogers N, Skinner M. Actions of anti-Mullerian hormone on the ovarian transcriptome to inhibit primordial to primary follicle transition. Reproduction. 2007;134(2):209\u201321.","journal-title":"Reproduction"},{"issue":"2","key":"4591_CR35","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1111\/j.1439-0531.2010.01739.x","volume":"46","author":"F Paulini","year":"2011","unstructured":"Paulini F, Melo EO. The role of oocyte-secreted factors GDF9 and BMP15 in follicular development and oogenesis. Reprod Domest Anim. 2011;46(2):354\u201361.","journal-title":"Reprod Domest Anim"},{"key":"4591_CR36","doi-asserted-by":"crossref","unstructured":"Kedem A, Fisch B, Garor R, Ben-Zaken A, Gizunterman T, Felz C, et al. Growth differentiating factor 9 (GDF9) and bone morphogenetic protein 15 both activate development of human primordial follicles in vitro, with seemingly more beneficial effects of GDF9. J Clin Endocrinol Metab. 2011;96(8):E1246\u201354.","DOI":"10.1210\/jc.2011-0410"},{"issue":"39","key":"4591_CR37","doi-asserted-by":"publisher","first-page":"24007","DOI":"10.1074\/jbc.M115.671487","volume":"290","author":"DG Mottershead","year":"2015","unstructured":"Mottershead DG, Sugimura S, Al-Musawi SL, Li JJ, Richani D, White MA, et al. Cumulin, an oocyte-secreted heterodimer of the transforming growth factor-\u03b2 family, is a potent activator of granulosa cells and improves oocyte quality. J Biol Chem. 2015;290(39):24007\u201320.","journal-title":"J Biol Chem"},{"issue":"1","key":"4591_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1477-7827-12-1","volume":"12","author":"Y Li","year":"2014","unstructured":"Li Y, Li R-Q, Ou S-B, Zhang N-F, Ren L, Wei L-N, et al. Increased GDF9 and BMP15 mRNA levels in cumulus granulosa cells correlate with oocyte maturation, fertilization, and embryo quality in humans. Reprod Biol Endocrinol. 2014;12(1):1\u20139.","journal-title":"Reprod Biol Endocrinol"},{"key":"4591_CR39","doi-asserted-by":"crossref","unstructured":"Shim SH, Ha HI, Jung YW, Shim SS, Cho YK, Kim JY, et al. Maternal antimullerian hormone as a predictor of fetal aneuploidy occurring in an early pregnancy loss. Obstet Gynecol Sci. 2015;58(6):494\u2013500.","DOI":"10.5468\/ogs.2015.58.6.494"},{"issue":"7","key":"4591_CR40","doi-asserted-by":"publisher","first-page":"10128","DOI":"10.18632\/aging.202772","volume":"13","author":"W Zhang","year":"2021","unstructured":"Zhang W, Zhang L, Liu Y, Li J, Xu X, Niu W, et al. Higher chromosomal aberration frequency in products of conception from women older than 32 years old with diminished ovarian reserve undergoing IVF\/ICSI. Aging (Albany NY). 2021;13(7):10128.","journal-title":"Aging (Albany NY)"},{"issue":"7","key":"4591_CR41","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s10815-010-9433-4","volume":"27","author":"BJ Plante","year":"2010","unstructured":"Plante BJ, Beamon C, Schmitt CL, Moldenhauer JS, Steiner AZ. Maternal antimullerian hormone levels do not predict fetal aneuploidy. J Assist Reprod Genet. 2010;27(7):409\u201314.","journal-title":"J Assist Reprod Genet"},{"key":"4591_CR42","doi-asserted-by":"crossref","unstructured":"Zarek SM, Mitchell EM, Sjaarda LA, Mumford SL, Silver RM, Stanford JB, et al. Antim\u00fcllerian hormone and pregnancy loss from the Effects of Aspirin in Gestation and Reproduction trial. Fertil Steril. 2016;105(4):946-52.","DOI":"10.1016\/j.fertnstert.2015.12.003"},{"key":"4591_CR43","doi-asserted-by":"crossref","unstructured":"Pereira N, Setton R, Petrini AC, Lekovich JP, Spandorfer SD. Is Anti-M\u00fcllerian Hormone Associated with IVF Outcomes in Young Patients with Diminished Ovarian Reserve? Womens Health (Lond). 2016;12(2):185\u201392.","DOI":"10.2217\/whe.15.102"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-022-04591-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-022-04591-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-022-04591-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T11:07:29Z","timestamp":1648897649000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-022-04591-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,2]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["4591"],"URL":"https:\/\/doi.org\/10.1186\/s12884-022-04591-5","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,2]]},"assertion":[{"value":"12 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of the Tianjin Central Hospital of Obstetrics and Gynecology (Protocol number: ZY2021006). All participating patients signed written informed consents. The research was conducted ethically in accordance with the World Medical Association Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"279"}}